I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Sallinen, Hanna
107
results:
Search for persons
X
Format
Online (107)
Mediatypes
E-Books (1)
Articles (Online) (44)
OpenAccess-fulltext (61)
Audio (Online) (1)
Languages
english (92)
finnish (4)
Sorted by: Relevance
Sorted by: Year
?
1
Neoadjuvant chemotherapy induces an elevation of tumour app..:
Reijonen, Milja
;
Holopainen, Erikka
;
Arponen, Otso
...
BMC Cancer. 23 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1186/..
?
2
Dynamic contrast-enhanced MRI to characterize angiogenesis ..:
Lindgren, Auni
;
Anttila, Maarit
;
Arponen, Otso
...
European Journal of Radiology. 165 (2023) - p. 110925 , 2023
Link:
https://doi.org/10.1016/..
?
3
AAV8-mediated sVEGFR2 and sVEGFR3 gene therapy combined wit..:
Kujala, Anni
;
Valkonen, Elina
;
Sallinen, Hanna
...
Frontiers in Medicine. 9 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
4
Treatment Free Intervals after Subsequent Chemotherapy Line..:
Sallinen, Hanna
;
Rintanen, Vivi
;
Keski-Nisula, Leea
.
Journal of Cancer Therapy. 12 (2021) 6 - p. 346-357 , 2021
Link:
https://doi.org/10.4236/..
?
5
Robotic-assisted laparoscopy is a feasible method for resec..:
Hiltunen, Janika
;
Eloranta, Marja-Liisa
;
Lindgren, Auni
...
Journal of International Medical Research. 49 (2021) 8 - p. 030006052110327 , 2021
Link:
https://doi.org/10.1177/..
?
6
Evaluation of Ovarian Cancer Care at the End of Life in a S..:
Sallinen, Hanna
;
Rintanen, Vivi
;
Keski-Nisula, Leea
.
Journal of Cancer Therapy. 12 (2021) 2 - p. 86-96 , 2021
Link:
https://doi.org/10.4236/..
?
7
High expression of Tie-2 predicts poor prognosis in primary..:
Sopo, Minna
;
Sallinen, Hanna
;
Hämäläinen, Kirsi
...
PLOS ONE. 15 (2020) 11 - p. e0241484 , 2020
Link:
https://doi.org/10.1371/..
?
8
Dynamic contrast-enhanced perfusion parameters in ovarian c..:
Lindgren, Auni
;
Anttila, Maarit
;
Rautiainen, Suvi
...
PLOS ONE. 14 (2019) 8 - p. e0221340 , 2019
Link:
https://doi.org/10.1371/..
?
9
Prognostic value of preoperative dynamic contrast-enhanced ..:
Lindgren, Auni
;
Anttila, Maarit
;
Arponen, Otso
...
European Journal of Radiology. 115 (2019) - p. 66-73 , 2019
Link:
https://doi.org/10.1016/..
?
10
Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher..:
Sopo, Minna
;
Anttila, Maarit
;
Hämäläinen, Kirsi
...
BMC Cancer. 19 (2019) 1 - p. , 2019
Link:
https://doi.org/10.1186/..
?
11
Primary and metastatic ovarian cancer: Characterization by ..:
Lindgren, Auni
;
Anttila, Maarit
;
Rautiainen, Suvi
...
European Radiology. 27 (2017) 9 - p. 4002-4012 , 2017
Link:
https://doi.org/10.1007/..
?
12
Serum angiopoietin-2 and soluble VEGFR-2 levels predict mal..:
Sallinen, Hanna
;
Heikura, Tommi
;
Koponen, Jonna
...
BMC Cancer. 14 (2014) 1 - p. , 2014
Link:
https://doi.org/10.1186/..
?
13
Antiangiogenic gene therapy with soluble VEGF‐receptors ‐1,..:
Sopo, Minna
;
Anttila, Maarit
;
Sallinen, Hanna
...
International Journal of Cancer. 131 (2012) 10 - p. 2394-2401 , 2012
Link:
https://doi.org/10.1002/..
?
14
In vivo SPECT/CT imaging of human orthotopic ovarian carcin..:
Huhtala, Tuulia
;
Laakkonen, Pirjo
;
Sallinen, Hanna
..
Nuclear Medicine and Biology. 37 (2010) 8 - p. 957-964 , 2010
Link:
https://doi.org/10.1016/..
?
15
Antiangiogenic Gene Therapy With Soluble VEGFR-1, -2, and -..:
Sallinen, Hanna
;
Anttila, Maarit
;
Narvainen, Johanna
...
Molecular Therapy. 17 (2009) 2 - p. 278-284 , 2009
Link:
https://doi.org/10.1038/..
1-15